ClinicalTrialsFinder

Adebrelimab (SHR-1316) Clinical Trials in Xuzhou, Jiangsu

1 recruitingXuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE

Cholangiocarcinoma CancerAdebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University122 enrolled4 locationsNCT06607276